OTCMKTS:PRLX

Parallax Health Sciences Stock Forecast, Price & News

$0.01
0.00 (0.00 %)
(As of 04/22/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.01
Now: $0.01
$0.01
50-Day Range
$0.01
MA: $0.01
$0.02
52-Week Range
$0.00
Now: $0.01
$0.06
VolumeN/A
Average Volume22,071 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Parallax Health Sciences, Inc. builds and expands an integrated digital healthcare network with products and services that provide remote communication, diagnosis, treatment, and monitoring of patients. The company offers remote healthcare products, including patent pending software and mobile apps, and other services, as well as electronic kits and devices from third-party licensed platforms that are designated towards a patient's primary health concern, such as diabetes, blood pressure, cardiovascular, general monitoring, etc.; and audio and video options that interface with the patient's healthcare providers. It also provides prescription medication dosage monitoring services; and behavioral health products comprising REBOOT, a proprietary behavioral health technology for an individual or an organization to transform the cost of treating and managing chronic illnesses that include pulmonary-COPD-asthma, diabetes, and cardiovascular diseases by effecting the modification of behavior in patients being treated for these chronic diseases. In addition, the company offers diagnostics products, which comprise Target System, a proprietary POC diagnostic immunoassay testing platform; and test cartridges for the areas of infectious diseases, cardiac markers, drugs of abuse, and various other medical conditions, as well as VT-1000 desktop analyzers, target antigen detection systems, and other products. Further, it provides SPARKS Mobile, a target system hand-held analyzer; COMPASS for behavioral modification; Fotodigm platform for remote patient monitoring, telehealth, and POC diagnostic testing services; and Intrinsic Code technology for actionable insights to behavior modification. The company was formerly known as Endeavor Power Corporation and changed its name to Parallax Health Sciences, Inc. in January 2014. Parallax Health Sciences, Inc. was founded in 2005 and is headquartered in Santa Monica, California.
Parallax Health Sciences logo

Industry, Sector and Symbol

Industry Diagnostics & Research
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:PRLX
CUSIPN/A
Phone+1-310-8994442
Employees9
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Next Earnings DateN/A
OptionableNot Optionable

Headlines

A vision realized
February 14, 2021 |  msn.com
News for Parallax Health Sciences Inc
December 25, 2020 |  markets.businessinsider.com
More Than Meets The AudioEye - Risks Outweigh The Bull Case
September 15, 2020 |  seekingalpha.com
Parallax Health Sciences Inc
July 30, 2020 |  www.bloomberg.com
Parallax Health Sciences Inc.
June 17, 2020 |  www.marketwatch.com
See More Headlines

MarketRank

Overall MarketRank

0.54 out of 5 stars

Medical Sector

1478th out of 2,024 stocks

Diagnostics & Research Industry

10th out of 15 stocks

Analyst Opinion: 0.0Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
$0.01
0.00 (0.00 %)
(As of 04/22/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive PRLX News and Ratings via Email

Sign-up to receive the latest news and ratings for PRLX and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Parallax Health Sciences (OTCMKTS:PRLX) Frequently Asked Questions

What stocks does MarketBeat like better than Parallax Health Sciences?

Wall Street analysts have given Parallax Health Sciences a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Parallax Health Sciences wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How has Parallax Health Sciences' stock been impacted by COVID-19 (Coronavirus)?

Parallax Health Sciences' stock was trading at $0.0790 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, PRLX stock has decreased by 87.3% and is now trading at $0.01.
View which stocks have been most impacted by COVID-19
.

Who are Parallax Health Sciences' key executives?

Parallax Health Sciences' management team includes the following people:
  • Mr. Paul R. Arena, CEO & Chairman (Age 62, Pay $567.82k)
  • Ms. Calli R. Bucci, CFO, Corp. Sec. & Director (Age 56, Pay $267.36k)
  • Mr. Nathaniel T. Bradley, CTO & Director (Age 44, Pay $227.66k)
  • Dr. David L. Stark, Pres (Age 63)

Who are some of Parallax Health Sciences' key competitors?

What other stocks do shareholders of Parallax Health Sciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Parallax Health Sciences investors own include Broadcom (AVGO), Baidu (BIDU), Catalyst Biosciences (CBIO), Celsion (CLSN), DocuSign (DOCU), Shopify (SHOP), Tilray (TLRY), Workhorse Group (WKHS), American Airlines Group (AAL) and AbbVie (ABBV).

What is Parallax Health Sciences' stock symbol?

Parallax Health Sciences trades on the OTCMKTS under the ticker symbol "PRLX."

How do I buy shares of Parallax Health Sciences?

Shares of PRLX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Parallax Health Sciences' stock price today?

One share of PRLX stock can currently be purchased for approximately $0.01.

How many employees does Parallax Health Sciences have?

Parallax Health Sciences employs 9 workers across the globe.

What is Parallax Health Sciences' official website?

The official website for Parallax Health Sciences is www.parallaxhealthsciences.com.

Where are Parallax Health Sciences' headquarters?

Parallax Health Sciences is headquartered at 1327 Ocean Ave Ste M, SANTA MONICA, CA 90401-1033, United States.

How can I contact Parallax Health Sciences?

Parallax Health Sciences' mailing address is 1327 Ocean Ave Ste M, SANTA MONICA, CA 90401-1033, United States. The company can be reached via phone at +1-310-8994442.


This page was last updated on 4/23/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.